Dr. Lerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3 Cooper Plz
Rm 215
Camden, NJ 08103Phone+1 856-963-2439Fax+1 856-338-9211
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2003 - 2006
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2001 - 2003
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1998
Certifications & Licensure
NJ State Medical License 2006 - 2025
PA State Medical License 2001 - 2012- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma Start of enrollment: 2013 Jul 12
Publications & Presentations
PubMed
- 12 citationsStereotactic Radiosurgery for Poor Performance Status PatientsGregory J. Kubicek, Alan Turtz, J. Xue, Ashish Patel, Gregory Richards
International Journal of Radiation Oncology, Biology, Physics. 2016-07-01 - 24 citationsPreoperative Radiosurgery for Soft Tissue Sarcoma.Gregory J. Kubicek, Tamara LaCouture, Maureen Kaden, Tae Won B. Kim, Nati Lerman
American Journal of Clinical Oncology. 2015-11-03 - 2 citationsHigh grade sarcoma, with predominant neuroectodermal and minor embryonal rhabdomyosarcomatous tumor of the uterus: A case report.Leona Chang, Miriam Enriquez, Nati Lerman, Robin Wilson-Smith
Gynecologic Oncology Reports. 2019-04-13
Press Mentions
Cancer Immunotherapy Clinical Study Approved for Phase 1June 7th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
